Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV001813714 | SCV002060907 | uncertain significance | Noonan syndrome and Noonan-related syndrome | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002359267 | SCV002657143 | uncertain significance | Cardiovascular phenotype | 2021-12-23 | criteria provided, single submitter | clinical testing | The p.T200S variant (also known as c.599C>G), located in coding exon 5 of the SOS1 gene, results from a C to G substitution at nucleotide position 599. The threonine at codon 200 is replaced by serine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV002468324 | SCV002763520 | uncertain significance | Noonan syndrome 4 | criteria provided, single submitter | clinical testing | ||
Genome- |
RCV002468323 | SCV002763521 | uncertain significance | Fibromatosis, gingival, 1 | criteria provided, single submitter | clinical testing |